Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Systemic Use Of A New Retinoid With And Without Local Dithranol Treatment In Generalized Psoriasis

C. Orfanos, U. Runne
Published 1976 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
giving little trouble undl 3 years ago. It then became more active, new lesions appeared, especially on her scalp, and the older ones enlarged. Topical steroids, combined with the use of Uvistat before light exposure, did not help her at all. She was started on chloroquin sulphate 200 mg twice daily, with initial relief. This had to be stopped after 5 weeks because of nausea, retching, photophobia, and weakness in the legs. After the chloroquine was stopped, she flared severely over the face and neck, and when seen in July she was both unsightly and depressed. She was given beta-carotene 50 mg three times daily, and had complete comfort within 2 weeks. This was maintained and all the lesions have regressed satisfactorily. She has been able to discondnue local steroids, and has had no sideeffects from the beta-carotene, which was stopped after 2 months.
This paper references



This paper is referenced by
10.1111/j.1346-8138.1983.tb01153.x
EFFECTS OF ORAL RETINOID ON THE SDS‐PAGE PROFILE OF STRATUM CORNEUM KERATIN IN PATIENTS WITH PSORIASIS
Y. Kitajima (1983)
10.1001/ARCHDERM.1987.01660250061018
Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
T. Kingston (1987)
10.1007/978-3-642-68023-6_25
Treatment of Psoriasis Vulgaris with a Low-dosage Ro 10-9359 (Tigason) Orally Combined with Corticosteroids Topically
Hee-sub Rhee (1981)
10.1111/j.1346-8138.2001.tb00140.x
A Case of Childhood Generalized Pustular Psoriasis Treated with Dapsone
H. J. Yu (2001)
10.1111/j.1365-2133.1980.tb01661.x
Oral retinoids‐present status
C. Orfanos (1980)
10.1056/NEJM199503023320907
Treatment of psoriasis.
M. Greaves (1995)
10.1016/S0378-4347(00)84320-0
Determination of plasma levels of two aromatic retinoic acid analogues with antipsoriatic activity by high-performance liquid chromatography.
G. Palmskog (1980)
10.1016/0163-7258(89)90075-2
Results of therapy for psoriasis using retinoid and photochemotherapy (RePUVA).
H. Hönigsmann (1989)
10.1016/S0190-9622(82)70057-X
A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis.
S. Glazer (1982)
10.1007/978-94-010-9851-9_23
Treatment of Disorders of Keratinization with an Oral Stereoisomer of Retinoic Acid
G. Peck (1978)
10.1016/S0190-9622(85)70223-X
Addition of short-contact anthralin therapy to an ultraviolet B phototherapy regimen: assessment of efficacy.
M. Lebwohl (1985)
10.1007/978-3-642-81091-6_43
Praktische Gesichtspunkte bei der ambulanten Behandlung der Psoriasis vulgaris
Gerd-K. Steigleder (1976)
10.1111/j.1365-2133.1987.tb04140.x
Treatment of severe psoriasis with etretin (RO 10‐1670)
A. Lassus (1987)
10.1016/S0021-9673(00)85078-5
Determiation of retinoic acid (13-cis- and all-trans-) and aromatic retinoic acid analogs possessing anti-tumor activity, in biological fluids by high-performance liquid chromatography
C. Puglisi (1978)
10.1016/0167-4889(86)90099-6
Modulation of rabbit keratocyte production of collagen, sulfated glycosaminoglycans and fibronectin by retinol and retinoic acid.
M. Kenney (1986)
History of Psoriasis
E. Wilson (2018)
10.2165/00003495-198734040-00003
The Retinoids
C. Orfanos (2012)
10.1016/0163-7258(81)90033-4
Chemotherapy of psoriasis and other skin disorders with oral retinoids.
D. Tsambaos (1981)
10.1016/S0190-9622(84)80007-9
Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexate.
M. M. Rosenbaum (1984)
10.1001/ARCHDERM.1981.01650030038018
Retinoids, cancer, and the skin.
P. Elias (1981)
10.1111/j.1749-6632.1981.tb12756.x
MODULATION OF GLYCOSAMINOGLYCAN BIOSYNTHESIS BY RETINOIDS
S. Shapiro (1981)
10.1001/ARCHDERM.1985.01660100077019
Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis.
R. Moy (1985)
10.1001/ARCHDERM.1988.01670040029016
Etretinate. Appropriate use in severe psoriasis.
N. Lowe (1988)
10.1016/S0190-9622(83)70033-2
Recent advances in the treatment of psoriasis.
E. Farber (1983)
10.1111/j.1365-2133.1982.tb00528.x
Inhibition of neutrophil migration by etretinate and its main metabolite
L. Dubertret (1982)
10.1111/j.1365-2133.1985.tb02085.x
Pharmacology and Treatment Maintenance treatment of psoriasis by Tigason: a double‐blind randomized clinical trial
L. Dubertret (1985)
10.1111/j.1346-8138.1982.tb02630.x
BIOCHEMICAL CHANGES AFTER THE ORAL ADMINISTRATION OF RETINOID IN THE HORNY LAYER OF PATIENTS WITH KERATINIZATION DISORDERS
T. Yoshiike (1982)
10.1016/S0190-9622(82)70051-9
The effects of retinoids on neutrophil functions in vitro.
C. Camisa (1982)
Nuclear Hormone Receptors: Perspectives for Dermatotherapy
M. Schmuth (2012)
10.1016/S0190-9622(85)70008-4
Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis.
N. Väätäinen (1985)
10.1016/s0190-9622(87)70037-1
Continuing medical education (Therapy)
C. Ellis (1987)
10.1007/BF00569100
Epidermal changes induced by oral excess of aromatic retinoid in guinea pigs
D. Tsambaos (2004)
See more
Semantic Scholar Logo Some data provided by SemanticScholar